TG Therapeutics (TGTX) Stock Price & Financial Analysis
TG Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About TG Therapeutics
What is the current stock price for TGTX?
As of the latest trading session, TGTX stock trades at $39.76. The 52-week range is $25.28–$44.65, with a day range of $39.51–$40.64.
What is the P/E ratio for TGTX?
TG Therapeutics's trailing P/E ratio is 14.2, meaning investors pay $14.2 for every $1 of annual earnings. The forward P/E is 7.2, reflecting analyst expectations for future earnings. TG Therapeutics operates in the Healthcare sector.
Does TGTX pay dividends?
TG Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for TGTX?
Analyst ratings and recommendations for TGTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of TGTX?
TG Therapeutics's market capitalization is $6.42B, classifying it as a mid-cap company. TG Therapeutics operates in the Healthcare sector within the Biotechnology industry.